Table 3.
Variable | Odds Ratio | 95% CI | P |
---|---|---|---|
Preoperative PSA, ng/mL | 1.02 | 1.00 to 1.03 | .04 |
Surgical margin (positive v negative) | 0.86 | .53 | |
Extracapsular extension (positive v negative) | 1.14 | .58 | |
Seminal vesicle invasion (positive v negative) | 1.81 | 1.12 to 2.94 | .02 |
Lymph node involvement (positive v negative) | 1.30 | .45 | |
Pathology Gleason sum | 1.10 | .38 | |
Months from operation to BCR | 0.99 | .14 | |
Years from BCR to bone scan | 1.00 | .95 | |
PSA doubling time, months | 1.00 | .72 | |
PSA slope, log (ng/mL/mo) | 2.29 | .06 | |
PSA velocity, ng/mL/mo | 1.07 | 1.04 to 1.09 | < .001 |
Trigger PSA, ng/mL | 1.015 | 1.012 to 1.019 | < .001 |
Abbreviations: PSA, prostate-specific antigen; BCR, biochemical recurrence.